Brief: Pliant Therapeutics Provides Update On BEACON-IPF, A Phase 2B/3 Trial In Patients With Idiopathic Pulmonary Fibrosis

Pliant Therapeutics

07/02/2025 22:03

Feb 7 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS PROVIDES UPDATE ON BEACON-IPF, A PHASE
2B/3
TRIAL IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    * PLIANT THERAPEUTICS INC - PAUSES ENROLLMENT AND DOSING IN
BEACON-IPF PHASE 2B TRIAL
    * PLIANT THERAPEUTICS INC - CURRENTLY ENROLLED PATIENTS WILL
REMAIN IN BEACON-IPF TRIAL
    * PLIANT THERAPEUTICS INC - INFORMING GLOBAL REGULATORY
AUTHORITIES
    * PLIANT THERAPEUTICS:  ENROLLMENT AND DOSING FOR ON
BEACON-IPF
PAUSED WHILE DATA IS REVIEWED TO UNDERSTAND DSMB'S RATIONALE

Source text:  ID:nGNX6YK74b 
Further company coverage:  PLRX.O 

 ((reuters.briefs@thomsonreuters.com;))